Efficacy of Interleukin-2 Gargle in the Treatment of Oral Mucosa Lesion in Pemphigus Vulgaris

NCT04023149 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Pemphigus Vulgaris

Interventions

DRUG: recombinant human interleukin-2 (rhIL-2)
DRUG: placebo

Sponsor

Second Xiangya Hospital of Central South University